CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,833,000 shares at $18.00 ($32,994,000)
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion Former 10% Owner acquired 1,960,425 shares (conversion)
- SC 13G Stake Amended Statement of Ownership
- 4 Conversion See Remark 1 acquired 1,013,853 shares (conversion)
- 4 Conversion See Remark 1 acquired 1,115,333 shares (conversion)
- 4 Open-market buy 10% owner bought 70,000 shares at $18.00 ($1,260,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 5,408,140 shares (conversion)
Page 11 of 14 · 266 filings